Bonus BioGroup Ltd.
BBIXF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $84,823 | $84,504 | $204,807 | $1,338,324 |
| - Cash | $6,859 | $12,937 | $53,624 | $79,453 |
| + Debt | $10,192 | $11,158 | $11,952 | $12,350 |
| Enterprise Value | $88,156 | $82,725 | $163,135 | $1,271,221 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | -$3,366 | -$4,097 |
| % Margin | – | – | – | – |
| EBITDA | -$26,203 | -$28,138 | -$35,149 | -$88,031 |
| % Margin | – | – | – | – |
| Net Income | -$27,826 | -$28,529 | -$38,703 | -$90,076 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.024 | -0.024 | -0.033 | -0.078 |
| % Growth | 2.5% | 26.3% | 57.6% | – |
| Operating Cash Flow | -$21,374 | -$26,397 | -$28,815 | -$39,839 |
| Capital Expenditures | -$342 | -$824 | -$6,389 | -$5,809 |
| Free Cash Flow | -$21,716 | -$27,221 | -$35,204 | -$45,648 |